HIGHLIGHTS
- who: Rui Guo from the Research Center for Experimental Medicine, State Key Laboratory of Medical Genomics, Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China have published the paper: RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway, in the Journal: (JOURNAL)
- what: This study demonstrated that suppressed the development of by regulating the activity of the MKK/p38 signaling pathway which is relevant to research on novel therapeutic targets for this malignant disease. Taken together, this study presents a novel role . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.